Insiders Eli Lilly and Company Xetra

Equities

Market Closed - Xetra Other stock markets 11:35:34 2024-07-17 am EDT			After market 12:28:45 pm
838.4 ^EUR	-3.88%		840.6	+0.27%

06:24pm	Global markets live: Adidas, TSMC, Vale, HSBC, J&J...
03:53pm	TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850	MT

Eli Lilly Names Gordon Brooks Interim Chief Financial Officer	Jul. 10	DJ
Eli Lilly Appoints Gordon Brooks Interim CFO	Jul. 10	MT
Eli Lilly Names Gordon Brooks Interim CFO	Jul. 10	MT
Eli Lilly and Company Announces Chief Financial Officer Changes	Jul. 10	CI
Eli Lilly and Company Announces Resignation of Anat Ashkenazi Resigned as Executive Vice President	Jul. 10	CI
VYNE Therapeutics Inc. Announces Appointment of Subhashis Banerjee, M.D. as Senior Vice President of Clinical Development	Jul. 09	CI
A weight loss ETF	Jun. 18	MT
Alzheon, Inc Announces Appointment of Gino Santini to Board of Directors	Jun. 12	CI
Alphabet Appoints Anat Ashkenazi as CFO	Jun. 05	MT
Eli Lilly's CFO Anat Ashkenazi Resigns	Jun. 05	MT
Eli Lilly CFO Anat Ashkenazi Resigns	Jun. 05	MT
Correction to Alphabet CFO Article	Jun. 05	DJ
Google Poaches Eli Lilly Finance Chief Ashkenazi -- Update	Jun. 05	DJ
Alphabet: Eli Lilly CFO recruited	Jun. 05	CF
Google Poaches Eli Lilly Finance Chief Ashkenazi	Jun. 05	DJ
Eli Lilly Chief Financial Officer Anat Ashkenazi Leaving	Jun. 05	DJ
Alphabet names Eli Lilly executive Anat Ashkenazi as CFO	Jun. 05	RE
Eli Lilly finance chief to leave company	Jun. 05	RE
Eli Lilly and Company Announces Resignation of Anat Ashkenazi as Executive Vice President	Jun. 05	CI
Eli Lilly and Company Announces Resignation of Anat Ashkenazi as Chief Financial Officer, Effective July 2024	Jun. 05	CI

No results for this search

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm EDT